Stocks
Becton, Dickinson and CompanyBDX
NYSEHealthcareMedical Devices$159.36-0.17%
A global medical technology company focused on improving drug delivery, enhancing infection prevention, and advancing diagnostic solutions. Investors track BDX for its leadership in medical devices and steady growth in healthcare infrastructure spending.
Market Cap: $57.7B52W Range: $127.59 – $187.35
Congressional Interest in Becton, Dickinson and Company (BDX)
12 members of Congress have disclosed 50 trades in Becton, Dickinson and Company (BDX), a Healthcare company. The buy/sell breakdown shows 23 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
12
Buys
23
Sells
27
Who in Congress Is Trading BDX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-27 | Alan Armstrong | buy | $1K – $15K |
| 2026-03-23 | Rohit Khanna | buy | $1K – $15K |